Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease.
Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, Yuyama N, Yamaya M, Nakayama K, Kubo H, Watanabe M, Sagara H, Sugiyama K, Tanaka H, Toda S, Hayashi H, Inoue H, Hoshino T, Shiraki A, Inoue M, Suzuki K, Aizawa H, Okinami S, Nagai H, Hasegawa M, Fukuda T, Green ED, Izuhara K. Nakao I, et al. Among authors: hayashi h. J Immunol. 2008 May 1;180(9):6262-9. doi: 10.4049/jimmunol.180.9.6262. J Immunol. 2008. PMID: 18424749
Effect of TYB-2285 on lung anaphylaxis in actively sensitized rats.
Watanabe A, Tominaga T, Shutoh H, Hayashi H, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Watanabe A, et al. Among authors: hayashi h. Gen Pharmacol. 1997 Feb;28(2):305-9. doi: 10.1016/s0306-3623(96)00226-1. Gen Pharmacol. 1997. PMID: 9013209
Effect of TYB-2285 on passive cutaneous anaphylaxis in rats.
Watanabe A, Tominaga T, Shutoh H, Hayashi H, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Watanabe A, et al. Among authors: hayashi h. Gen Pharmacol. 1997 Feb;28(2):311-5. doi: 10.1016/s0306-3623(96)00225-x. Gen Pharmacol. 1997. PMID: 9013210
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
Fujita Y, Matsuoka H, Chiba Y, Tsurutani J, Yoshida T, Sakai K, Nakura M, Sakamoto R, Makimura C, Ohtake Y, Tanaka K, Hayashi H, Takahama T, Tanizaki J, Koyama A, Nishio K, Nakagawa K. Fujita Y, et al. Among authors: hayashi h. Mol Clin Oncol. 2024 Nov 29;22(2):14. doi: 10.3892/mco.2024.2809. eCollection 2025 Feb. Mol Clin Oncol. 2024. PMID: 39720462 Free PMC article.
Effect of Increasing or Decreasing Use of Polypharmacy on Recovery of Activities of Daily Living in Patients With Stroke in the Recovery-Phase Rehabilitation Ward: A Retrospective Cohort Study Using Propensity Score Matching.
Hanaoka S, Iwabuchi K, Hirai T, Seki T, Hayashi H. Hanaoka S, et al. Among authors: hayashi h. Stroke Res Treat. 2024 Dec 13;2024:2381790. doi: 10.1155/srat/2381790. eCollection 2024. Stroke Res Treat. 2024. PMID: 39712951 Free PMC article.
Evaluation of immune checkpoint inhibitor efficacy for solid tumors with CD274 (PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based on a nationwide database.
Nakayama T, Takahama T, Chiba Y, Shiraishi N, Kawakami H, Yonesaka K, Nakagawa K, Hayashi H. Nakayama T, et al. Among authors: hayashi h. J Immunother Cancer. 2024 Dec 18;12(12):e010130. doi: 10.1136/jitc-2024-010130. J Immunother Cancer. 2024. PMID: 39694703 Free PMC article.
6,577 results